NKF 2010 Hyperphosphatemia Coverage - Renal and Urology News

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Study Finds No Link Between FGF-23 and Dietary Phosphorus

Jody A. Charnow April 29, 2011

LAS VEGAS—Fibroblast growth factor 23 (FGF-23) is not significantly associated with dietary phosphorus or urinary phosphorus excretion, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

Phosphate Binder May Reduce the Number of Hospitalization Days

Jody A. Charnow April 17, 2010

Using sevelamer instead of calcium-based binders (CBBs) to treat hyperphosphatemia in dialysis patients can significantly decrease the number of days of hospitalization.

Sevelamer Carbonate May Impair Calcitriol Bioavailability

Jody A. Charnow April 17, 2010

Sevelamer carbonate significantly decreases the bioavailability of oral calcitriol when the two drugs are administered together, but lanthanum carbonate does not, show data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Fluid Intake with Phosphate Binders Quantified

Jody A. Charnow April 17, 2010

The daily fluid intake with phosphate binder (PB) pills accounts for a significant portion of the daily fluid restriction in hemodialysis (HD) patients, suggest data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

High Phosphorus Linked to Lower Pulse Pressure in Women with CKD

Jody A. Charnow April 16, 2010

Higher serum phosphorus is associated with lower pulse pressure in women, but not men, with non-dialysis dependent CKD, according to researchers at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Proton Pump Inhibitors May Improve Phosphate Control

Jody A. Charnow April 16, 2010

Proton pump inhibitors (PPIs) taken concurrently with phosphate binders may increase phosphate control in hemodialysis (HD) patients, according to researchers who presented their data at the National Kidney Foundation's 2010 Spring Clinical Meetings..

Lanthanum Carbonate Rapidly Reduces Phosphorus Levels

Jody A. Charnow April 16, 2010

Lanthanum carbonate rapidly reduces serum phosphorus levels in dialysis patients, according to an analysis of data from four clinical trials reported at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Lanthanum Carbonate Provides Long-Term Phosphate Control

Jody A. Charnow April 15, 2010

Lanthanum carbonate provides sustained long-term reduction of serum phosphorus in dialysis patients, according to a study presented at the National Kidney Foundation 2010 Spring Clinical Meetings.

Findings Stress the Need for Phosphorus Counseling of CKD Patients

Jody A. Charnow April 15, 2010

The phosphorus content of a typical American diet significantly increases levels of fibroblast growth factor-23 (FGF-23), a pilot study suggests.

Switching to Nocturnal Hemodialysis Beneficial

Jody A. Charnow April 15, 2010

ORLANDO, Fla.—Patients converted from in-center conventional hemodialysis (ICHD) to in-center nocturnal hemodialysis (NHD) have improvements in serum phosphorus levels and blood pressure (BP) control, according to two studies of the same cohort of 418 patients.